ARTICLE | Clinical News
XmAb5871: Phase IIa data
February 9, 2015 8:00 AM UTC
Top-line data from 23 evaluable patients with active RA on a background of stable non-biologic DMARD therapy in the double-blind Phase IIa portion of a Phase Ib/IIa trial showed that twice-weekly 10 m...